Gutam Shah
Achillion Pharmaceuticals has named Gautam Shah its new executive VP.
Previously senior VP, Shah will also continue to work as the firm’s chief compliance officer.
President and CEO Michael Kishbauch said: “Aided by the strong working relationships he has cultivated with the regulatory agencies, his tenure has been marked by significant accomplishments including regulatory submissions for all four of our clinical HCV programs and advancements in the formulation and manufacturing of our compounds."